Arriello s.r.o
Arriello s.r.o is recorded as a service provider in 7 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 7 of 7 trials · Latest update first
A Phase 3, Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of SYNB1934 in Patients with PKU (SYNPHENY-3)
Sponsor Synlogic Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
A 12-month, randomized, single-blind, placebo-controlled exposure-response study of TCD601 (siplizumab) in new onset type 1 diabetes patients (STRIDE)
Sponsor Itb-Med AB
- Start (EU)
- Latest update
- Estimated end
Open-Label Safety, Pharmacokinetic, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) with Hereditary Angioedema Type I or II
Sponsor Kalvista Pharmaceuticals Limited
- Start (EU)
- Latest update
- Estimated end
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II A Pharmacokinetic Subtrial in Adolescent Patients with Hereditary Angioedema Type I or II Participating in the KVD900-302 Trial
Sponsor Kalvista Pharmaceuticals Limited
- Start (EU)
- Latest update
- Estimated end
A 60 month, single-arm, proof-of-concept study to induce allogeneic tolerance in deceased donor liver transplant recipients using siplizumab, an anti-CD2 antibody in combination with cyclophosphamide and splenectomy.
Sponsor Itb-Med AB
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomized, double-blind, placebo-controlled, Phase 2 study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with nonsquamous non-small cell lung cancer who have progressed on immunotherapy
Sponsor iTeos Belgium
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Multicenter, Open-Label, Phase I/II Study of EOS884448 in combination with standard of care and/or investigational therapies in participants with advanced solid tumors
Sponsor iTeos Belgium
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Arriello s.r.o?
The 2026-10-09 snapshot links Arriello s.r.o to 7 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance, Aggregate report and line listing submission activities, SAE processing, SAE processing, DSUR. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Arriello s.r.o?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Arriello s.r.o conducted?
The linked trials record locations in 17 countries, including Italy, Spain, France, Belgium, Germany. These are trial locations, not confirmed office locations or countries where Arriello s.r.o delivered services.
What can this page tell me about Arriello s.r.o's trial experience?
Browse 7 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Arriello s.r.o. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Arriello s.r.o.